Moderna
the National Institute of Allergy
Company’s
NIAID
the National Institutes of Health
NIH
the NIAID Vaccine Research Center
VRC
the Coalition for Epidemic Preparedness Innovations
CEPI
Chief Technical Operations and Quality Officer
MA
the Spike (S
Middle Eastern Respiratory Syndrome (MERS
RSV
CMV
Moderna’s
FDA
CoronavirusCoronaviruses
»
Juan Andres
H10N8
Zika
Coronaviruses
Bat Coronavirus
mRNA
No matching tags
No matching tags
Bethesda
Maryland
U.S.mRNA-1273
Norwood
Wuhan
Hubei Province
China
No matching tags
mRNA-1273 is part of the Company’s core prophylactic vaccines modality, which has had six positive Phase 1 clinical readouts across six different vaccines over the past four years.About mRNA-1273mRNA-1273 is an mRNA vaccine against the novel coronavirus encoding for a prefusion stabilized form of the Spike (S) protein, which was designed by Moderna in collaboration with NIAID.
As said here by Brian Wang